Polaris Venture Management Co VI’s Editas Medicine EDIT Stock Holding History

Polaris Venture Management Co VI’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$43.1M	Sell	1,797,144 -1,000,002	-36%	-$19M	100%	1
2017 Q2	$46.9M	Sell	2,797,146 -1,000,000	-26%	-$18M	100%	1
2017 Q1	$84.8M	Hold	3,797,146	–	–	100%	1
2016 Q4	$61.6M	Sell	3,797,146 -359,027	-9%	-$5.45M	100%	1
2016 Q3	$56M	Sell	4,156,173 -500,000	-11%	-$10.2M	98.5%	1
2016 Q2	$114M	Hold	4,656,173	–	–	99.47%	1
2016 Q1	$161M	Buy	+4,656,173	New	+$122M	96.46%	1

Other funds holding EDIT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Polaris Venture Management Co VI's EDIT Position: Q3 2017 in Review

Polaris Venture Management Co VI reduced its Editas Medicine (EDIT) stake by 36% in Q3 2017, selling an estimated $19M and leaving 1,797,144 shares worth $43.1M. The position accounts for 100% of the portfolio, ranked #1.

Polaris Venture Management Co VI first reported a position in EDIT in Q1 2016 and has held it in 7 quarters since. The position peaked at $161M in Q1 2016. 116 funds tracked by Wall St. Rank hold EDIT as of Q3 2017.

Polaris Venture Management Co VI held 1,797,144 shares of Editas Medicine worth $43.1M as of Q3 2017.
Polaris Venture Management Co VI sold 1,000,002 Editas Medicine shares in Q3 2017, an estimated $19M.
Editas Medicine made up 100% of Polaris Venture Management Co VI's portfolio in Q3 2017, its #1 holding.
Polaris Venture Management Co VI first reported a position in Editas Medicine in Q1 2016 and has held it in 7 quarters since.
Polaris Venture Management Co VI's Editas Medicine position peaked at $161M in Q1 2016.
116 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2017.

Based on Polaris Venture Management Co VI's 13F filing for Q3 2017, filed 14 Nov 2017.